BiotechTube
Home/LoQus23 Therapeutics/Dr. Caroline Benn
DC

Dr. Caroline Benn

Chief Scientific Officer & Co-founder

LoQus23 Therapeutics

Therapeutic Areas

NeurologyRare Diseases

LoQus23 Therapeutics Pipeline

DrugIndicationPhase
Somatic Expansion Inhibitor ProgramHuntington's DiseasePreclinical
Platform ExpansionOther Triplet Repeat Expansion DisordersResearch

Leadership Team at LoQus23 Therapeutics

DD
Dr. David Reynolds
Chief Executive Officer & Co-founder
DD
Dr. David Hardick
Head of Chemistry
DA
Dr. Amanda Davis
VP of Operations and Development
DT
Deb Tonge
Finance Director
DC
Dr. Cyrus Mozayeni
Chair of the Board
View full LoQus23 Therapeutics profile